您现在的位置: 首页> 研究主题> autoimmune

autoimmune

autoimmune的相关文献在1989年到2022年内共计175篇,主要集中在内科学、肿瘤学、外科学 等领域,其中期刊论文175篇、相关期刊58种,包括四川生理科学杂志、世界胃肠病学杂志:英文版、免疫学期刊(英文)等; autoimmune的相关文献由811位作者贡献,包括David S. Younger、Terumi Kamisawa、George K Koukoulis等。

autoimmune—发文量

期刊论文>

论文:175 占比:100.00%

总计:175篇

autoimmune—发文趋势图

autoimmune

-研究学者

  • David S. Younger
  • Terumi Kamisawa
  • George K Koukoulis
  • George N Dalekos
  • Hiromasa Ohira
  • Hirotoshi Kataoka
  • Isabela Bruna Pires Borges
  • Jian Zhang
  • Kalliopi Zachou
  • Kazuichi Okazaki
  • 期刊论文

搜索

排序:

年份

期刊

    • Michael Au; Nikola Mitrev; Rupert W Leong; Viraj Kariyawasam
    • 摘要: BACKGROUND Little is known about the safety and efficacy of using two or more biologics for the treatment of immune-mediated diseases,including Crohn’s disease(CD).CASE SUMMARY This case report and narrative review demonstrate the potential safety of dual biologic therapy(DBT)in a 45-year-old female with two separate immunemediated diseases.She had a history of multiple sclerosis for which she was receiving treatment with ocrelizumab,and she had been recently diagnosed with CD after presenting with diarrhoea.The CD diagnosis was confirmed radiologically,endoscopically,histologically,and biochemically.The patient received treatment with vedolizumab,a gut-specific inhibitor of theα4β7 integrin on leukocytes.No adverse reactions were observed for the duration of treatment.The safety of ocrelizumab and vedolizumab for the treatment of different immune-mediated diseases was demonstrated.CONCLUSION DBT may be a safe and effective option for the treatment of refractory disease or multiple immunemediated diseases.Newer biologics,which have improved safety profiles and gut specificity,may provide promising avenues for treatment.However,caution must be exercised in the appropriate selection of biologics given their inherent immunosuppressive properties,side effects,and efficacy profiles.Current evidence suggests that biologic therapy is not associated with a worse prognosis in patients with coronavirus disease 2019,but treatment decisions should be made in a multidisciplinary setting.Further research from controlled trials is needed to better understand the safety profile of DBT in CD.The immunopathological mechanisms underlying DBT also remain to be clarified.
    • Xiao-chan Chen; Shan He; Jing Xue
    • 摘要: Dear editor,Shrinking lung syndrome(SLS),a rare complication of autoimmune inflammatory diseases,is mainly associated with systemic lupus erythematosus(SLE),with an occurrence in 1%-2%of cases.^([1])It is characterized by restrictive defects on pulmonary function tests(PFTs)associated with reduced lung volume.SLS has also been reported in cases of primary Sjogren syndrome(pSS),^([2,3])scleroderma,^([4])rheumatoid arthritis,^([5])mixed connective tissue disease,⑹and undifferentiated connective tissue disease.Herein,we present three case reports of SLS,including two patients with SLE and one patient with adultonset StilFs disease(AOSD)(Table 1).
    • Jing Zou; Zikai Zhao; Guoping Zhang; Qing Zhang; Ilmari Pyykko
    • 摘要: The etiology and underlying mechanism of Meniere's disease(MD)development are still unknown,although inflammation and autoimmunity have been implicated as underlying mechanisms.The human endolymphatic sac(ES)has been reported to have innate and adaptive immune capacity in local immune reactions.In vivo demonstration of inflammation of the ES in patients with MD is missing in the literature.We report the case of a 47-year-old female patient diagnosed with unilateral MD with genetic variants and cytokine markers indicating inflammation and vascular congestion of the ES.Endolymphatic hydrops in the right cochlea(grade 2)and vestibulum(grade 3)were detected using MRI.She carried heterozygous variants in MEFV(c.442G>C),IRF8(c.1157G>T),ADA(c.445C>T),PEPD(c.151G>A),NBAS(c.4049T>C),CSF2RB(c.2222C>T),HPS6(c.277G>T),IL2RB(c.1109C>T),IL12RB1(c.1384G>T),IL17RC(c.260_271del GCAAGAGC TGGG),LIG1(c.746G>A),RAG1(c.650C>A),and SLX4(c.1258G>C,c.5072A>G).In the serum,the levels of granulocyte colony-stimulating factor(G-CSF),macrophage inflammatory protein 1a,and IL7 were significantly elevated,and the level of IL2Ra was reduced.Intratympanic administration of dexamethasone temporarily alleviated her hearing loss.Her vertigo was significantly relieved but remained slight after ES administration of corticosteroids.
    • Colleen M Noviello
    • 摘要: Autoantibodies targeting neuronal membrane proteins can cause encephalitis,seizures,and severe behavioral abnormalities.While antibodies for several neuronal targets have been identified,structural details on how they regulate function are unknown.Here we determined cryo-electron microscopy structures of antibodies derived from an encephalitis patient bound to theγ-aminobutyric acid type A(GABAA)receptor.
    • Vu Thuong Nguyen; Lawrence S. Chan
    • 摘要: Background: SARS-CoV-2, the virus responsible for the current COVID-19 infection pandemic, has caused substantial damage and negative impacts in the world, including physical sickness, mental illness, death, society lock down, work interruption, and productivity reduction. From the onset in early 2020, the pandemic has not yet totally subsided as of July 2022. Although great efforts have been made to understand the nature of this pandemic by the medical and scientific communities, a comprehensive review of this pandemic has not been reported. Purpose: We aimed to perform a thorough review of the subject in order to come to a better understanding of the origin of the virus, its mutations and their corresponding health effects, its pathophysiology, and its responses to therapeutic intervention. A more comprehensive set of data on these subject matters, if available, would give healthcare providers a valuable tool in formulating the best methods to respond to the current disease and prevent the disease from spreading in the future. Method: An extensive literature search on the subjects of COVID-19 was conducted regarding the possible origin of the viral pathogen, its evolutionary changes and health impacts, the world’s responses to COVID-19 and outcomes of their responses, and healthcare professional’s actions to understand and manage the disease and the results of their actions. To gather these data, websites of PubMed and Google Scholar were utilized for the search with the following keywords: Pandemic, COVID-19, coronavirus, SARS, SARS-CoV, SARS-CoV-2, origin, pathogenesis, and treatment. Results: Our review revealed data that points to an interesting autoimmune phenomenon where most seriously sick patients affected by COVID-19 were documented by an IgA-dominant immune response to the pathogen, along with a neutrophil-directed infiltration to the vital organ in the lung aveola, resulting in critical lung injury, leading to respiratory failure, multi-organ failure, and death. Surprisingly, this IgA-mediated and neutrophil-directed disease pattern is nearly identical to a group of IgA-mediated autoimmune skin diseases, such as dermatitis herpetiformis, IgA bullous dermatosis, and IgA pemphigus, which respond well to treatment by dapsone, a sulfone class of antibiotic/anti-inflammatory drug. Moreover, the usefulness of dapsone was supported by a small clinical study. In addition, systemic corticosteroid, a trusted anti-inflammatory medication, has been used in this pandemic with variable degrees of success. Conclusion: The data collected from our review of the subject, together with our prior search knowledge, compel us to conclude that the underlying pathophysiology that causes serious respiratory distress and multi-organ failure is most likely to be autoimmune in nature and that strategies to counter these multifacet autoimmune disorders would be the most valuable in life-saving. Specifically, we identified clinical and laboratory evidence pointing to IgA autoimmune reaction as a key factor that causes significant mortality in many patients. Accordingly, we proposed the utilization of a combination of dapsone, corticosteroid, and anti-thrombotic drugs in severely ill patients at the earliest point of the disease process. The autoimmune multi-organ syndrome may explain the pathogenesis of COVID-19 as well as Post-COVID conditions and may guide healthcare professionals in a better direction to manage the disease. The possible origin of the viral pathogen may shed light on a better understanding of the pathogenesis of the disease.
    • Daniel Vasile Balaban; Iulia Enache; Marina Ciochina; Alina Popp; Mariana Jinga
    • 摘要: Celiac disease(CD)is well recognized as a systemic,chronic autoimmune disease mainly characterized by gluten-sensitive enteropathy in genetically predisposed individuals but with various extraintestinal features.One of the affected organs in CD is the pancreas,consisting of both endocrine and exocrine alterations.Over the last decades there has been increasing interest in the pancreatic changes in CD,and this has been reflected by a great number of publications looking at this extraintestinal involvement during the course of CD.While pancreatic endocrine changes in CD,focusing on type 1 diabetes mellitus,are well documented in the literature,the relationship with the exocrine pancreas has been less studied.This review summarizes currently available evidence with regard to pancreatic exocrine alterations in CD,focusing on risk of pancreatitis in CD patients,association with autoimmune pancreatitis,prevalence and outcomes of pancreatic exocrine insufficiency in newly diagnosed and gluten-free diet treated CD patients,and the link with cystic fibrosis.In addition,we discuss mechanisms behind the associated pancreatic exocrine impairment in CD and highlight the recommendations for clinical practice.
    • Blossom Damania
    • 摘要: Epstein-Barr virus(EBV)is a ubiquitous,oncogenic virus that is associated with a number of different human malignancies as well as autoimmune disorders.The expression of EBV viral proteins and non-coding RNAs contribute to EBV-mediated disease pathologies.The virus establishes life-long latency in the human host and is adept at evading host innate and adaptive immune responses.In this review,we discuss the life cycle of EBV,the various functions of EBV-encoded proteins and RNAs,the ability of the virus to activate and evade immune responses,as well as the neoplastic and autoimmune diseases that are associated with EBV infection in the human population.
    • Nathalie Conrad
    • 摘要: Background:Some autoimmune diseases are associated with an increased risk of cardiovascular disease.We aimed to determine whether or not this is true,and to what extent,for a broad range of autoimmune conditions.Methods:In this population-based study,we used linked primary and secondary care records from the Clinical Practice Research Datalink(CPRD),GOLD and Aurum datasets,to assemble a cohort of individuals across the UK who were newly diagnosed with any of 19 autoimmune diseases between Jan 1,2000,and Dec 31,2017,younger than 80 years at diagnosis,and free of cardiovascular diseases up to 12 months after diagnosis.
    • Oscar Leonel García Rodas; Francisco Sánchez Salinas; Scherezada Maria Isabel Mejia Loza
    • 摘要: Common variable immunodeficiency (CVID) is one of the most prevalent primary immunodeficiency disorders, characterized by an alteration in the maturation of B lymphocytes. Patients with this condition are redisposed to a higher risk of infections. Despite being an immune deficiency disorder, the prevalence of autoimmune disorders is reported in more than 20% of patients. The likelihood of patients’ gastrointestinal tract being affected is relatively low, close to 6%. We present the case of a 22-year-old man with a history of CVID without medical treatment, who presented with upper gastrointestinal bleeding secondary to esophageal varices due to cirrhotic portal hypertension. Infectious and toxic causes of cirrhosis were ruled out. Histological changes compatible with autoimmune hepatitis (AIH) were documented by liver biopsy. The diagnosis of autoimmune diseases is a challenge in the presence of IDCV, we highlight the importance of establishing a timely diagnosis and an intentional search for these conditions to offer timely treatment and avoid late complications.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号